Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Warren Fiskus

Showing results (31-40 of 94) with videos related to

Pageof 10
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 7, 2004
Superior activity of the combination of histone deacetylase inhibitor LAQ824 and the FLT-3 kinase inhibitor PKC412 against human acute myelogenous leukemia cells with mutant FLT-3Purva Bali, Prince George, Pamela Cohen, et al.
Cancer Research|November 17, 2005
Abrogation of heat shock protein 70 induction as a strategy to increase antileukemia activity of heat shock protein 90 inhibitor 17-allylamino-demethoxy geldanamycinFei Guo, Kathy Rocha, Purva Bali, et al.
Blood|June 23, 2010
Overcoming resistance to histone deacetylase inhibitors in human leukemia with the redox modulating compound β-phenylethyl isothiocyanateYumin Hu, Weiqin Lu, Gang Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 31, 2012
Superior efficacy of a combined epigenetic therapy against human mantle cell lymphoma cellsWarren Fiskus, Rekha Rao, Ramesh Balusu, et al.
Pharmacotherapy|June 26, 2013
Preclinical and phase I results of decitabine in combination with midostaurin (PKC412) for newly diagnosed elderly or relapsed/refractory adult patients with acute myeloid leukemiaCasey B Williams, Suman Kambhampati, Warren Fiskus, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 1, 2024
Editor's Note: Superior Efficacy of a Combined Epigenetic Therapy against Human Mantle Cell Lymphoma CellsWarren Fiskus, Rekha Rao, Ramesh Balusu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 22, 2010
Role of CAAT/enhancer binding protein homologous protein in panobinostat-mediated potentiation of bortezomib-induced lethal endoplasmic reticulum stress in mantle cell lymphoma cellsRekha Rao, Srilatha Nalluri, Warren Fiskus, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 15, 2020
Editor's Note: Role of CAAT/Enhancer Binding Protein Homologous Protein in Panobinostat-mediated Potentiation of Bortezomib-induced Lethal Endoplasmic Reticulum Stress in Mantle Cell Lymphoma CellsRekha Rao, Srilatha Nalluri, Warren Fiskus, et al.
Molecular Cancer Therapeutics|April 8, 2010
Treatment with panobinostat induces glucose-regulated protein 78 acetylation and endoplasmic reticulum stress in breast cancer cellsRekha Rao, Srilatha Nalluri, Ravindra Kolhe, et al.
Molecular Endocrinology (Baltimore, Md.)|June 13, 2015
miR-137 Targets p160 Steroid Receptor Coactivators SRC1, SRC2, and SRC3 and Inhibits Cell ProliferationVijay Kumar Eedunuri, Kimal Rajapakshe, Warren Fiskus, et al.
Pageof 10

Showing results (31-40 of 94) with videos related to

Sort By:
Pageof 10
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 7, 2004
Superior activity of the combination of histone deacetylase inhibitor LAQ824 and the FLT-3 kinase inhibitor PKC412 against human acute myelogenous leukemia cells with mutant FLT-3Purva Bali, Prince George, Pamela Cohen, et al.
Cancer Research|November 17, 2005
Abrogation of heat shock protein 70 induction as a strategy to increase antileukemia activity of heat shock protein 90 inhibitor 17-allylamino-demethoxy geldanamycinFei Guo, Kathy Rocha, Purva Bali, et al.
Blood|June 23, 2010
Overcoming resistance to histone deacetylase inhibitors in human leukemia with the redox modulating compound β-phenylethyl isothiocyanateYumin Hu, Weiqin Lu, Gang Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 31, 2012
Superior efficacy of a combined epigenetic therapy against human mantle cell lymphoma cellsWarren Fiskus, Rekha Rao, Ramesh Balusu, et al.
Pharmacotherapy|June 26, 2013
Preclinical and phase I results of decitabine in combination with midostaurin (PKC412) for newly diagnosed elderly or relapsed/refractory adult patients with acute myeloid leukemiaCasey B Williams, Suman Kambhampati, Warren Fiskus, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 1, 2024
Editor's Note: Superior Efficacy of a Combined Epigenetic Therapy against Human Mantle Cell Lymphoma CellsWarren Fiskus, Rekha Rao, Ramesh Balusu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 22, 2010
Role of CAAT/enhancer binding protein homologous protein in panobinostat-mediated potentiation of bortezomib-induced lethal endoplasmic reticulum stress in mantle cell lymphoma cellsRekha Rao, Srilatha Nalluri, Warren Fiskus, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 15, 2020
Editor's Note: Role of CAAT/Enhancer Binding Protein Homologous Protein in Panobinostat-mediated Potentiation of Bortezomib-induced Lethal Endoplasmic Reticulum Stress in Mantle Cell Lymphoma CellsRekha Rao, Srilatha Nalluri, Warren Fiskus, et al.
Molecular Cancer Therapeutics|April 8, 2010
Treatment with panobinostat induces glucose-regulated protein 78 acetylation and endoplasmic reticulum stress in breast cancer cellsRekha Rao, Srilatha Nalluri, Ravindra Kolhe, et al.
Molecular Endocrinology (Baltimore, Md.)|June 13, 2015
miR-137 Targets p160 Steroid Receptor Coactivators SRC1, SRC2, and SRC3 and Inhibits Cell ProliferationVijay Kumar Eedunuri, Kimal Rajapakshe, Warren Fiskus, et al.
Pageof 10